| Mr Robert Joshua Logan, PA-C | |
|
613 23rd St Ste 140, Ashland, KY 41101 | |
| (606) 326-1675 | |
| (606) 326-1436 |
| Full Name | Mr Robert Joshua Logan |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 613 23rd St Ste 140, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699105304 | NPI | - | NPPES |
| 7100515940 | Medicaid | KY | |
| 0243582 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
News Archive
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2010.
An international survey published today (Thursday 6 October) in Europe's leading cardiology journal, European Heart Journal, reveals that fewer than half of the heart patients in the study who smoked quit after suffering their first coronary event, with one out of five continuing to smoke despite advice to stop.
Mayo Clinic joins a coalition of seven hospitals in launching Civica Rx, a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications. The company, which is organized as a Delaware nonstock, not-for-profit corporation, will be headquartered in Utah.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.
The measure would bar any cuts from taking place before the Health and Human Services secretary determines they are necessary. Meanwhile, in other Medicare news, ProPublica reports that federal regulators are in the process of making kidney dialysis clinic data more accessible to the public.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Joshua Logan, PA-C Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-6200 | Mr Robert Joshua Logan, PA-C 613 23rd St Ste 140, Ashland, KY 41101 Ph: (606) 326-1675 |
News Archive
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2010.
An international survey published today (Thursday 6 October) in Europe's leading cardiology journal, European Heart Journal, reveals that fewer than half of the heart patients in the study who smoked quit after suffering their first coronary event, with one out of five continuing to smoke despite advice to stop.
Mayo Clinic joins a coalition of seven hospitals in launching Civica Rx, a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications. The company, which is organized as a Delaware nonstock, not-for-profit corporation, will be headquartered in Utah.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.
The measure would bar any cuts from taking place before the Health and Human Services secretary determines they are necessary. Meanwhile, in other Medicare news, ProPublica reports that federal regulators are in the process of making kidney dialysis clinic data more accessible to the public.
› Verified 6 days ago